Clinical TrialsSearch results
Number of results: 446
- Recruitment status
- Title of the study
- Health Condition
- Primary sponsor
- Date of registration
Other
- Establishment of surveillance system for the longstanding ulcerative colitis patients Comparative study of efficacy for the targeted biopsy and the step biopsy
- Ulcerative colitis
- Teikyo University School of Medicine
- 2009-01-05
Other
- SC versus IV isatuximab in combination with pomalidomide and dexamethasone in RRMM
- Plasma cell myeloma recurrent
- Tanaka Tomoyuki
- 2022-10-29
Not yet recruiting
- Providing evidence for long-term care and developing a support system for evidence-based long-term care using Long-term care Information system For Evidence (LIFE)
- A chronic condition or disability, requiring periodic, intermittent, or continuous care.
- Tamiya Nananako
- 2022-01-14
Not yet recruiting
- Developing a feedback system and evidence generation using LIFE data for evidence based long term care
- Care-needs level, Activities of daily living, malnutrition, pressure ulcer
- Tamiya Nanako
- 2022-10-04
Other
- Post-marketing Clinical Trial of Pioglitazone - A Study of Preventive Effects on the Onset and Recurrence of Macrovascular Events -
- Type2 Diabetes
- Takeda Pharmaceutical Company Limited
- 2008-09-10
Other
- A study in subjects with impaired glucose tolerance (IGT) to evaluate effects of AO-128 on prevention of type 2 diabetes mellitus (Phase III, multicenter, randomized, double-blind, placebo-controlled, parallel-group comparison)
- Impaired glucose tolerance (IGT)
- Takeda Pharmaceutical Company Limited
- 2008-04-07
Other
- A Phase 2/3 Study of SYR-322 as an Add-on to an Alpha-Glucosidase Inhibitor
- Type 2 diabetes mellitus
- Takeda Pharmaceutical Company Limited
- 2008-10-01
Other
- A Phase 2/3 Study of SYR-322 as an Add-on to a Thiazolidine
- Type 2 diabetes mellitus
- Takeda Pharmaceutical Company Limited
- 2008-10-01
Other
- A Phase 2/3 Study of SYR-322 as an Add-on to a Sulfonylurea
- Type 2 diabetes mellitus
- Takeda Pharmaceutical Company Limited
- 2009-04-01
Other
- A Phase 2/3 Study of SYR-322 as an Add-on to a Metformin
- Type 2 diabetes mellitus
- Takeda Pharmaceutical Company Limited
- 2009-04-01